U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 1 to 20 of 32

Tests names and labsConditionsGenes, analytes, and microbesMethods

Plasminogen activator inhibitor-1 deficiency, 613329, Autosomal recessive, Autosomal dominant (Congenital plasminogen activator inhibitor type 1 deficiency) (SERPINE1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Soft tissue sarcoma panel (12 genes)

Molecular Genetics Laboratory North York General Hospital
Canada
212
  • C Sequence analysis of the entire coding region

SERPINE1 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Blood Coagulation Panel

Centogene AG - the Rare Disease Company
Germany
110112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Transcription of plasminogen activator inhibitor, modulator of (Congenital plasminogen activator inhibitor type 1 deficiency) (SERPINE1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Bleeding Disorders Panel

PreventionGenetics, part of Exact Sciences
United States
7879
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Coagulation Factor Deficiency Panel

PreventionGenetics, part of Exact Sciences
United States
2120
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G

Quest Diagnostics Nichols Institute San Juan Capistrano
United States
11
  • T Targeted variant analysis

Plasminogen activator inhibitor-1 deficiency (sequence analysis of SERPINE1 gene)

CGC Genetics Unilabs
Portugal
11
  • C Sequence analysis of the entire coding region

Plasminogen Activator Inhibitor 1 Polymorphism

Duzen Laboratories Duzen BBAGUAS
Turkey
11
  • T Targeted variant analysis

PAI-1 DNA analysis - 4G / 5G

Genetiks Genetic Diagnosis Center Genetic Diseases Evaluation Center
Turkey
11
  • C Sequence analysis of the entire coding region

Comprehensive Bleeding Disorder Panel

Versiti Diagnostic Laboratories Versiti, Inc
United States
8066
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

SERPINE1 - Genetic Analysis

Versiti Diagnostic Laboratories Versiti, Inc
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

PAI 4G/5G POLYMORPHISM

BioReference Health
United States
11
  • T Targeted variant analysis

Factor II (Prothrombin) G20210A Genotyping, Factor V Leiden Genotyping, SERPINE1 (PAI-1) 4G/5G Genotyping

PathGroup
United States
43
  • T Targeted variant analysis

Factor V Leiden Genotyping, MTHFR C677T and A1298C Genotyping, and SERPINE1 (PAI-1) 4G/5G Genotyping

PathGroup
United States
43
  • T Targeted variant analysis

Factor V Leiden Genotyping and SERPINE1 (PAI-1) 4G/5G Genotyping

PathGroup
United States
22
  • T Targeted variant analysis

MTHFR C677T and A1298C Genotyping and SERPINE1 (PAI-1) 4G/5G Genotyping

PathGroup
United States
32
  • T Targeted variant analysis

Factor II (Prothrombin) G20210A Genotyping, Factor V Leiden Genotyping, MTHFR C677T and A1298C Genotyping, SERPINE1 (PAI-1) 4G/5G Genotyping

PathGroup
United States
64
  • T Targeted variant analysis

Factor II (Prothrombin) G20210A Genotyping and SERPINE1 (PAI-1) 4G/5G Genotyping

PathGroup
United States
42
  • T Targeted variant analysis

Results: 1 to 20 of 32

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.